Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in Systolic Heart Failure and Subclinical Hypothyroidism
NCT02316743Phase 4Unknown
- Sponsor
- Université de Sherbrooke
- Start
- Dec 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levothyroxine sodium in hypothyroidism, sponsored by Université de Sherbrooke. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT02316743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316743.